Evaluate Safety and Efficacy of High-dose Melphalan HCL for Injection in MM Patients With Auto-HSC Transplantation
- First Posted Date
- 2024-05-22
- Last Posted Date
- 2024-05-23
- Lead Sponsor
- CASI Pharmaceuticals (China) Co., Ltd.
- Target Recruit Count
- 67
- Registration Number
- NCT06425276
- Locations
- 🇨🇳
Peking University People's Hospital, Beijing, China
© Copyright 2025. All Rights Reserved by MedPath